Is the cost of treating cancer in Singapore still too high?
· 28 min · S4 E4
Episode Is the cost of treating cancer in Singapore still too high?
In a bid to curb the cost of cancer treatment, the Singapore government announced an approved drug list where the most cost-effective drugs can be claimed by the national insurance schemes. Yet, the cost of treatment can spiral - in part thanks to rising insurance premiums. Are people paying too much? How has this new drug list shifted things and should you worry if you don't have insurance? Steven Chia speaks to Associate Professor Ravindran Kanesvaran, chairperson of Singapore Cancer Society's Cancer Treatment Fund Committee, Evelyn Goh deputy CEO and chief advisory officer of Providend and Gina Ho, a 43-year-old general manager and cancer survivor.
See omnystudio.com/listener for privacy information.
Links in the notes 1
Transcript
Shows are listed from Apple Podcasts' charts and directory, and Podcast Index where it is used. Every show and episode belongs to its publisher and plays from the publisher's own feed; this site hosts none of them. Explicit shows are for adult profiles only, and children’s profiles hear only children’s shows. More about this list.